Top Markets
#1 PulseChain PulseChain +45.01%
#2 SkyAI SkyAI +12.67%
#3 Meteora Meteora +11.24%
#4 Glidr Glidr +9.27%
#5 OPENLOOT OPENLOOT +8.94%
#6 Unit Pump Unit Pump +8.52%
#7 Pump.fun Pump.fun +8.52%
#8 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +7.55%
#9 eCash eCash +7.18%
#10 Cash Cat Cash Cat +7.15%
Coin of the day
PulseChain PulseChain
Settings
Language
ENGLISH
Currency
USD
Theme
TCI GENE Inc. TCI GENE Inc.

TCI GENE Inc.

6879
Rank in Stocks #28090
TCI GENE Inc., based in Taipei, Taiwan, specializes in delivering personalized... TCI GENE Inc., based in Taipei, Taiwan, specializes in delivering personalized preventative healthcare solutions. The company offers an extensive range of genetic screenings, including tests for nutrient metabolism, weight management, and specific G2 and ACE2 markers. Its diverse product portfolio encompasses dietary supplements, skincare items, anti-aging treatments, products designed to support children's development, and solutions targeting Alzheimer's disease. Additionally, TCI GENE provides specialized serums for DNA typing and offers professional nutrition counseling services.
Share Price
$1.08
Last synced: 2026-08-19
Market Cap
$28.61M
Change (1 day)
0.00%
Change (1 year)
-22.93%
Country
TW
Trade TCI GENE Inc. (6879)

Category

Healthcare
P/E ratio for TCI GENE Inc. (6879)
P/E ratio as of 2026 TTM: 0
According to TCI GENE Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for TCI GENE Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.